vs
Side-by-side financial comparison of AMC Networks Inc. (AMCX) and Enovis CORP (ENOV). Click either name above to swap in a different company.
AMC Networks Inc. is the larger business by last-quarter revenue ($594.8M vs $548.9M, roughly 1.1× Enovis CORP). AMC Networks Inc. runs the higher net margin — -9.3% vs -104.1%, a 94.7% gap on every dollar of revenue. On growth, AMC Networks Inc. posted the faster year-over-year revenue change (-0.8% vs -2.2%). AMC Networks Inc. produced more free cash flow last quarter ($40.4M vs $29.1M). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs -0.1%).
AMC Networks Inc. is an American independent mass media and entertainment corporation headquartered in 11 Penn Plaza, New York City. The company owns and operates the eponymous cable channel, BBC America, IFC, Sundance TV, and We TV. It also owns the art house movie theater IFC Center in New York City; the independent film companies Independent Film Company and RLJE Films, the anime licensor Sentai Filmworks, the premium subscription streaming services AMC+, IFC Films Unlimited, Acorn TV, All...
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
AMCX vs ENOV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $594.8M | $548.9M |
| Net Profit | $-55.5M | $-571.1M |
| Gross Margin | 49.7% | 59.9% |
| Operating Margin | -8.6% | -101.7% |
| Net Margin | -9.3% | -104.1% |
| Revenue YoY | -0.8% | -2.2% |
| Net Profit YoY | 80.5% | 18.8% |
| EPS (diluted) | $-0.97 | $-9.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $594.8M | $548.9M | ||
| Q3 25 | $561.7M | $564.5M | ||
| Q2 25 | $600.0M | $558.8M | ||
| Q1 25 | $555.2M | — | ||
| Q4 24 | $599.3M | $561.0M | ||
| Q3 24 | $599.6M | $505.2M | ||
| Q2 24 | $625.9M | $525.2M | ||
| Q1 24 | $596.5M | $516.3M |
| Q4 25 | $-55.5M | $-571.1M | ||
| Q3 25 | $76.5M | $-36.7M | ||
| Q2 25 | $50.3M | $-56.0M | ||
| Q1 25 | $18.0M | — | ||
| Q4 24 | $-284.5M | $-703.2M | ||
| Q3 24 | $41.4M | $-31.5M | ||
| Q2 24 | $-29.2M | $-18.6M | ||
| Q1 24 | $45.8M | $-72.0M |
| Q4 25 | 49.7% | 59.9% | ||
| Q3 25 | 48.2% | 59.3% | ||
| Q2 25 | 52.7% | 59.5% | ||
| Q1 25 | 51.8% | — | ||
| Q4 24 | 51.2% | 54.8% | ||
| Q3 24 | 52.0% | 56.7% | ||
| Q2 24 | 55.2% | 55.0% | ||
| Q1 24 | 54.5% | 57.7% |
| Q4 25 | -8.6% | -101.7% | ||
| Q3 25 | 9.9% | -3.0% | ||
| Q2 25 | 10.7% | -8.4% | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | -42.4% | -118.5% | ||
| Q3 24 | 15.6% | -6.3% | ||
| Q2 24 | 1.7% | -8.4% | ||
| Q1 24 | 18.5% | -6.8% |
| Q4 25 | -9.3% | -104.1% | ||
| Q3 25 | 13.6% | -6.5% | ||
| Q2 25 | 8.4% | -10.0% | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | -47.5% | -125.4% | ||
| Q3 24 | 6.9% | -6.2% | ||
| Q2 24 | -4.7% | -3.5% | ||
| Q1 24 | 7.7% | -13.9% |
| Q4 25 | $-0.97 | $-9.99 | ||
| Q3 25 | $1.38 | $-0.64 | ||
| Q2 25 | $0.91 | $-0.98 | ||
| Q1 25 | $0.34 | — | ||
| Q4 24 | $-6.23 | $-12.69 | ||
| Q3 24 | $0.76 | $-0.58 | ||
| Q2 24 | $-0.66 | $-0.34 | ||
| Q1 24 | $1.03 | $-1.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $502.4M | $33.6M |
| Total DebtLower is stronger | $1.8B | $1.4B |
| Stockholders' EquityBook value | $981.9M | $2.0B |
| Total Assets | $3.9B | $4.4B |
| Debt / EquityLower = less leverage | 1.78× | 0.67× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $502.4M | $33.6M | ||
| Q3 25 | $716.8M | $44.1M | ||
| Q2 25 | $866.4M | $38.5M | ||
| Q1 25 | $870.2M | — | ||
| Q4 24 | $784.6M | $48.2M | ||
| Q3 24 | $816.4M | $35.4M | ||
| Q2 24 | $802.6M | $35.0M | ||
| Q1 24 | $690.5M | $66.3M |
| Q4 25 | $1.8B | $1.4B | ||
| Q3 25 | $1.9B | $1.4B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | $1.3B | ||
| Q3 24 | $2.3B | $1.3B | ||
| Q2 24 | $2.4B | $1.3B | ||
| Q1 24 | $2.3B | $1.3B |
| Q4 25 | $981.9M | $2.0B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $971.7M | $2.6B | ||
| Q1 25 | $888.8M | — | ||
| Q4 24 | $855.6M | $2.6B | ||
| Q3 24 | $1.1B | $3.3B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.1B | $3.3B |
| Q4 25 | $3.9B | $4.4B | ||
| Q3 25 | $4.2B | $5.0B | ||
| Q2 25 | $4.4B | $4.9B | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $4.4B | $4.7B | ||
| Q3 24 | $4.8B | $5.6B | ||
| Q2 24 | $4.9B | $5.4B | ||
| Q1 24 | $4.9B | $5.5B |
| Q4 25 | 1.78× | 0.67× | ||
| Q3 25 | 1.82× | 0.54× | ||
| Q2 25 | 2.27× | 0.53× | ||
| Q1 25 | 2.62× | — | ||
| Q4 24 | 2.73× | 0.52× | ||
| Q3 24 | 2.10× | 0.40× | ||
| Q2 24 | 2.26× | 0.41× | ||
| Q1 24 | 2.17× | 0.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $49.2M | $82.6M |
| Free Cash FlowOCF − Capex | $40.4M | $29.1M |
| FCF MarginFCF / Revenue | 6.8% | 5.3% |
| Capex IntensityCapex / Revenue | 1.5% | 9.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $272.4M | $22.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.2M | $82.6M | ||
| Q3 25 | $44.8M | $47.8M | ||
| Q2 25 | $102.8M | $-1.6M | ||
| Q1 25 | $108.8M | — | ||
| Q4 24 | $58.1M | $88.3M | ||
| Q3 24 | $62.2M | $53.6M | ||
| Q2 24 | $104.4M | $7.8M | ||
| Q1 24 | $150.9M | $-36.2M |
| Q4 25 | $40.4M | $29.1M | ||
| Q3 25 | $42.0M | $3.4M | ||
| Q2 25 | $95.7M | $-44.9M | ||
| Q1 25 | $94.2M | — | ||
| Q4 24 | $37.6M | $35.1M | ||
| Q3 24 | $53.9M | $2.4M | ||
| Q2 24 | $95.2M | $-31.6M | ||
| Q1 24 | $144.1M | $-73.1M |
| Q4 25 | 6.8% | 5.3% | ||
| Q3 25 | 7.5% | 0.6% | ||
| Q2 25 | 16.0% | -8.0% | ||
| Q1 25 | 17.0% | — | ||
| Q4 24 | 6.3% | 6.3% | ||
| Q3 24 | 9.0% | 0.5% | ||
| Q2 24 | 15.2% | -6.0% | ||
| Q1 24 | 24.2% | -14.2% |
| Q4 25 | 1.5% | 9.7% | ||
| Q3 25 | 0.5% | 7.9% | ||
| Q2 25 | 1.2% | 7.7% | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 3.4% | 9.5% | ||
| Q3 24 | 1.4% | 10.1% | ||
| Q2 24 | 1.5% | 7.5% | ||
| Q1 24 | 1.1% | 7.2% |
| Q4 25 | — | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMCX
| Subscription And Circulation | $314.8M | 53% |
| Advertising | $124.9M | 21% |
| Other | $79.1M | 13% |
| License | $74.8M | 13% |
| Related Party | $1.2M | 0% |
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
